BioLineRx Ownership | Who Owns BioLineRx?


OverviewForecastChartTranscripts

BioLineRx Ownership Summary


BioLineRx is owned by 0.47% institutional investors, 4.00% insiders, and 95.53% retail investors. Cvi is the largest institutional shareholder, holding 1.13% of BLRX shares. Fidelity Nasdaq Composite Index is the top mutual fund, with 0.04% of its assets in BioLineRx shares.

BLRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockBioLineRx0.47%4.00%95.53%
SectorHealthcare Stocks 35.49%11.78%52.72%
IndustryBiotech Stocks 34.84%11.71%53.45%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Cvi815.68K1.13%$461.68K
Xtx topco10.94K0.27%$25.27K
Pvg asset management123.58K0.17%$70.43K
Rhumbline advisers2.35K0.06%$5.43K
Bnp paribas arbitrage, snc1.80K0.04%$4.14K
Wells fargo & company/mn1.75K0.04%$4.03K
Citigroup1.73K0.04%$3.99K
Citadel advisors11.20K0.02%$6.34K
Ubs group529.000.01%$1.22K
Susquehanna group, llp87.22K0.01%$18.53K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Cvi815.68K0.40%$461.68K
Pvg asset management123.58K0.28%$70.43K
Xtx topco10.94K0.00%$25.27K
Nemes rush group250.000.00%$575.00
Susquehanna group, llp87.22K-$18.53K
Advisor group26.00-$59.00
Rockefeller capital management12.00-$28.00
Cutter & co brokerage---
Baader bank aktiengesellschaft---
Orin green financial---

Top Buyers

HolderShares% AssetsChange
Cvi815.68K0.40%815.68K
Pvg asset management123.58K0.28%123.58K
Susquehanna group, llp87.22K-69.18K
Royal bank of canada20.20K-20.20K
Xtx topco10.94K0.00%10.94K

Top Sellers

HolderShares% AssetsChange
Highbridge capital management---1.01M
Alyeska investment group---866.50K
Envestnet asset management---239.19K
Values first advisors---166.45K
Atria investments---133.97K

New Positions

HolderShares% AssetsChangeValue
Cvi815.68K0.40%815.68K$461.68K
Pvg asset management123.58K0.28%123.58K$70.43K
Royal bank of canada20.20K-20.20K$4.00K
Xtx topco10.94K0.00%10.94K$25.27K

Sold Out

HolderChange
Jpmorgan chase-1.00
Tradewinds capital management-200.00
Simplex trading-1.98K
Group one trading-3.19K
Newedge advisors-4.30K

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 202612-20.00%19,491-59.18%-35.13%3-50.00%350.00%
Dec 31, 2025157.14%47,75073.04%1238.06%620.00%2-
Sep 30, 202514-26.32%27,595-58.33%-24.85%5-50.00%2-33.33%
Jun 30, 20251-6---1---
Dec 31, 202432-5.88%1,985,190-20.52%-0.04%1515.38%6-45.45%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Nasdaq Composite Index999.000.04%-

Insider Transactions Trends


DateBuySell
2026 Q4--
2026 Q1--
2025 Q1--
2024 Q4--
2024 Q1--

BLRX Ownership FAQ


Who Owns BioLineRx?

BioLineRx shareholders are primarily institutional investors at 0.47%, followed by 4.00% insiders and 95.53% retail investors. The average institutional ownership in BioLineRx's industry, Biotech Stocks , is 34.84%, which BioLineRx falls below.

Who owns the most shares of BioLineRx?

BioLineRx’s largest shareholders are Cvi (815.68K shares, 1.13%), Xtx topco (10.94K shares, 0.27%), and Pvg asset management (123.58K shares, 0.17%). Together, they hold 1.56% of BioLineRx’s total shares outstanding.

Does Blackrock own BioLineRx?

BlackRock is not among the top 10 institutional shareholders of BioLineRx.

Who is BioLineRx’s biggest shareholder by percentage of total assets invested?

Cvi is BioLineRx’s biggest shareholder by percentage of total assets invested, with 0.40% of its assets in 815.68K BioLineRx shares, valued at 461.68K$.

Who is the top mutual fund holder of BioLineRx shares?

Fidelity Nasdaq Composite Index is the top mutual fund holder of BioLineRx shares, with 0.04% of its total shares outstanding invested in 999 BioLineRx shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools